Skip to main content

person
dana-farber.org
Search

Featured Specialties
Find a Physician
Find a Clinical Trial
Refer a Patient
Contact Us

2025 American Society of Clinical Oncology (ASCO)

Preview oral abstract and poster presentation schedules, new releases, awards and honors, and much more from Dana-Farber at ASCO 2025

News Releases

Dana-Farber Researchers Identify Interventions for Breast Cancer and Colorectal Cancer That Could Redefine Standard of Care
T-DXd Plus Pertuzumab Outperforms Standard of Care for First-Line Treatment of Advanced HER2-Positive Breast Cancer
Diet Influences Survival After Stage III Colon Cancer, Dana-Farber Study Finds
Adding Immune Checkpoint Inhibitor to Standard Chemotherapy Regimine Improves Outcomes in Stage 3 Colon Cancer, Study Finds
ADC Combination Outperforms Standard Treatment of Advanced Triple Negative Breast Cancer
EQUAL Study Launches Lung Cancer Screening Trial for People at High Risk

Resources

ASCO 2025 Dana-Farber Oral Abstracts and Clinical Science Symposium Presentations
ASCO 2025 Dana-Farber Poster Presentations

Events

ASCO 2025: The STAT Recap, June 4, 2025, 1pm-2pm EDT

Awards & Honors

OncLive's Giants in Cancer Care Award Recipient - Gastrointestinal Cancer: Brian M. Wolpin, M.D., MPH – Dana-Farber Cancer Institute

Follow us on social media

Facebook
Instagram
LinkedIn
X (formerly Twitter)

@DanaFarber Cancer Institute - Information on our expert cancer care and advanced research
@DanaFarberNews - Your source for Dana-Farber news
@DFBC_PedCare - Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Bluesky

Connect with us

About Us
Research
Medical Oncology Spotlight
Find a Clinical Trial
Find a Physician
Refer a Patient
Clinical Resources